|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
German Clinical Trials Register |
|
Last refreshed on:
|
8 April 2024 |
|
Main ID: |
DRKS00013881 |
|
Date of registration:
|
26/04/2018 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Mental attitude of patients and therapists towards the pharmaceutical therapy of alcohol dependence
|
|
Scientific title:
|
Mental attitude of patients and therapists towards the pharmaceutical therapy of alcohol dependence |
|
Date of first enrolment:
|
15/06/2018 |
|
Target sample size:
|
300 |
|
Recruitment status: |
Complete |
|
URL:
|
http://drks.de/search/en/trial/DRKS00013881 |
|
Study type:
|
observational |
|
Study design:
|
Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Germany
| | | | | | | |
|
Contacts
|
|
Name:
|
Julian
Wellensiek |
|
Address:
|
Kaiser-Karl-Ring 20
53111
Bonn
Germany |
|
Telephone:
|
02285517355 |
|
Email:
|
julian.wellensiek@lvr.de |
|
Affiliation:
|
LVR-Klinik Bonn |
|
|
Name:
|
Julian
Wellensiek |
|
Address:
|
Kaiser-Karl-Ring 20
53111
Bonn
Germany |
|
Telephone:
|
02285517355 |
|
Email:
|
julian.wellensiek@lvr.de |
|
Affiliation:
|
LVR-Klinik Bonn |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Existing alcohol-dependency (ICD10 F10.2), no acute episode of psychotic disorder or intoxication, minimum age of 18 years, sufficient comprehension of the German language in order to fully understand questions asked.
Exclusion criteria: No existing alcohol-dependency (ICD10: F10.2), acute episode of psychotic disorder, intoxication, younger than 18 years, insufficient comprehension of the German language hence not capable of fully understanding questions asked.
Age minimum:
18 Years
Age maximum:
None
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
F10.2
|
|
F10.2
|
|
Intervention(s)
|
|
Group 1: Aim of this study is to identify factors on behalf of 300 alcohol dependent patients (ICD10 F10.2) and addiction-therapists inhibiting recommendation, administration and usage (i.e. implementation) of Anti-Craving drugs despite their proven efficacy and recommendation by alcohol-use disorder guidelines by using questionnaire-based systemical clinical interviewing on patients and a questionnaire-based survey on therapists. Estimated time-range for questioning are 6 months.
|
|
Primary Outcome(s)
|
Primary Aim: To identify factors on behalf of alcohol dependent patients and addiction-therapists inhibiting recommendation, administration and usage of Anti-Craving drugs.
Patient questionning: Personal systemic clinical interview of out- and inpatient alcohol-dependant patients. The patient´s questionnaire includes questions on sociodemographic data, somatic and psychiatric illness, substance abuse and addiction, current medication and knowledge on and experience with Anti-Craving drugs.
Therapist questionning: The therapist´s questionnaire includes questions on sociodemographic data, work experience in the therapy of substance dependence, knowledge of Anti-Craving drugs and their attitude towards these substances. Answers to the questionnaire are recorded qualitativley and quantitatvely. The patients´questioning is planned to start in July 2018, the therapists´questioning in September 2018
|
|
Source(s) of Monetary Support
|
|
LVR-Klinikum Essen, Kliniken und Institut der Universität Duisburg-Essen, Klinik für Abhängiges Verhalten und Suchtmedizin
|
|
Ethics review
|
Status: Approved
Approval date: 16/04/2018
Contact:
ethikkommission@uk-essen.de
Ethik-Kommission der Medizinischen Fakultät der Universität Duisburg-Essen
+49-201-7233637
ethikkommission@uk-essen.de
|
|